FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 3, 1996, Pages 299-305

  Giudici, D ^a   Briatico, G ^a   Cominato, C ^a   Zaccheo, T ^a   Iehle, C ^a   Nesi, M ^a   Panzeri, A ^a   Di Salle, E ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; FCE 28260; FINASTERIDE; FLUTAMIDE; ISOENZYME; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROSTATE HYPERTROPHY; PROSTATE VENTRAL LOBE; RADIOIMMUNOASSAY; RAT;

EID: 0029766909     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00040-4     Document Type: Article

References (26)

1. B.W. Metcalf M.A. Levy D.A. Holt Inhibitors of steroid 5α-reductase in benign prostatic hyperplasia, male pattern baldness and acne TIPS 10 1989 491 495
2. F.H. Schröder 5α-Reductase inhibitors and prostatic disease Clin. Endocrinol. 41 1994 139 147
3. J.R. Brooks C. Berman R.L. Primka G.F. Reynolds G.H. Rasmusson 5α-Reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the rat Steroids 47 1986 1 19
4. G.J. Gormley E. Stoner R.C. Bruskewitz J. Imperato-McGinley P.C. Walsh J.D. McConnell G.L. Andriole J. Geller B.R. Bracken J.S. Tenover E. Darracott Vaughan F. Pappas A. Taylor B. Binkowitz J. Ng The effect of finasteride in men with benign prostatic hyperplasia New Engl. J. Med. 327 1992 1185 1191
5. B.W. Metcalf D.A. Holt M.A. Levy J.M. Erb J.I. Heaslip M. Brandt H.-J. Oh Potent inhibition of human steroid 5α-reductase (EC 1.3.1.30) by 3-androstene-3-carboxylic acids Bioorg. Chem. 17 1989 372 376
6. R.E. Johnsonbaugh B.R. Cohen E.M. McCormack F.W. George J.D. Wilson Effect of 14 days treatment with epristeride, an uncompetitive 5α-reductase inhibitor, on serum and prostatic testosterone and dihydrotestosterone in men with benign prostatic hyperplasia J. Urol. 149 1993 432A
7. S. Andersson D.W. Russell Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases 2nd edn Proc. Natn. Acad. Sci. U.S.A. 87 1990 3640 3644
8. E.P. Jenkins S. Andersson J. Imperato-McGinley J. Wilson D.W. Russell Genetic and pharmacological evidence for more than one human steroid 5α-reductase J. Clin. Invest. 89 1992 293 300
9. A.E. Thigpen R. Silver J.M. Guileyardo M.L. Casey J.D. McConnell D.W. Russell Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression J. Clin. Invest. 92 1993 903 910
10. S. Andersson D.M. Berman E.P. Jenkins D.W. Russell Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism Nature 354 1991 159 161
11. G. Harris B. Azzolina W. Baginsky G. Cimis G.H. Rasmusson R.L. Tolman C.R.H. Raetz K. Ellsworth Identification of selective inhibition of an isozyme of steroid 5α-reductase in human scalp 2nd edn Proc. Natn. Acad. Sci. U.S.A. 89 1992 10787 10791
12. M.A. Levy M. Brandt K.M. Sheedy J.T. Dinh D.A. Holt L.M. Garrison D.J. Bergsma B.W. Metcalf Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5α-reductase isoform 2 J. Steroid Biochem. Molec. Biol. 48 1994 197 206
13. D.H. Peters E.M. Sorkin Finasteride, a review of its potential in the treatment of benign prostatic hyperplasia Drugs 46 1993 177 208
14. 5-steroid isomerase J. Med. Chem. 37 1994 2352 2360
15. E. di Salle G. Briatico D. Giudici G. Ornati T. Zaccheo F. Buzzetti M. Nesi A. Panzeri Novel aromatase and 5α-reductase inhibitors J. Steroid Biochem. Molec. Biol. 49 1994 289 294
16. T. Liang M.A. Cascieri A.H. Cheung G.F. Reynolds G.H. Rasmusson Species differences in prostatic steroid 5α-reductases of rat, dog and human Endocrinology 117 1985 571 579
17. + 4-ene-oxido-reductase; EC 1.3.1.22) in a stable and active form J. Steroid Biochem. Molec. Biol. 38 1991 73 77
18. E. di Salle D. Giudici G. Briatico G. Ornati A. Panzeri Hormonal effects of turosteride, a 5α-reductase inhibitor, in the rat J. Steroid Biochem. Molec. Biol. 46 1993 549 555
19. C. Iehlè S. Délos O. Filhol P.M. Martin Baculovirusdirected expression of human prostatic steroid 5α-reductase 1 in an active form J. Steroid Biochem. Molec. Biol. 46 1993 177 182
20. C. Iehlè S. Délos O. Guirou R. Tate J.P. Raynaud P.M. Martin Human prostatic steroid 5α-reductase isoforms: a comparative study of selective inhibitors J. Steroid Biochem. Molec. Biol. 54 1995 273 279
21. R.I. Silver E.L. Wiley D.L. Davis A.E. Thigpen D.W. Russell J.D. McConnell Expression and regulation of steroid 5α-reductase 2 in prostate disease J. Urol. 152 1994 433 437
22. K. Normington D.W. Russell Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes Evidence for distinct physiological functions J. Biol. Chem. 267 1992 19548 19554
23. D. Giudici G. Briatico L. Biagini C. Cominato A. Panzeri E. di Salle Effect of the 5α-reductase inhibitors turosteride, finasteride and epristeride on prostatic testosterone and dihydrotestosterone in the rat J. Endocr. Invest. 17 1994 51
24. K.S. Hirsch C.D. Jones J.E. Audia S. Andersson L. McQuaid N.B. Stamm B.L. Neubauer P. Pennington R.E. Tooney D.W. Russell LY 191704: a selective, nonsteroidal inhibitor of human steroid 5α-reductase type 1 2nd edn Proc. Natn. Acad. Sci. U.S.A. 90 1993 5277 5281
25. R.K. Bakshi G.F. Patel G.H. Rasmusson W.F. Baginsky G. Cimis K. Ellsworth B. Chang H. Bull R.L. Tolman G.S. Harris 4,7β-Dimethyl-4-azacholestan-3-one (MK 386) and related 4-azasteroids as selective inhibitors of human type 1 5α-reductase J. Med. Chem. 37 1994 3871 3874
26. J. Schwartz A. Van Hecken I. De Lepeleire D. Wang M. Depre P. De Schepper B. Gertz Pharmacodynamics of MK-386: a novel inhibitor of 5α-reductase type 1 Clin. Pharmacol. Ther. 57 1995 171